PP16 GPCRs, Growth Factors and Inhibins - Mechanisms, Genetics and Drug Discovery

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Growth Factor/Tyrosine Kinase/G Protein-Coupled Receptor/Intracelluar Signaling & Biology-
Saturday, April 2, 2016: 11:30 AM-11:45 AM
Room 253 (BCEC)
Chair:
To Be Determined

Disclosure Not Provided: MTM, MTM
Giampaolo Trivellin, PhD1, Ivana Bjelobaba, PhD2, Adrian F Daly, MB BCh, PhD3, Darwin Omar Larco, PhD4, Nadine Dupuis5, Fabio R Faucz, PhD1, Pierre Geubelle5, Albert Thiry6, Leonor Palmeira, PhD3, T John Wu, PhD4, Stanko S Stojilkovic2, Benjamin Feldman, PhD7, Julien Hanson5, Stefano Costanzi, PhD8, Albert Beckers, MD, PhD3, Davide Calebiro, MD, PhD9 and Constantine A Stratakis, MD1, (1)Section on Endocrinology & Genetics, NICHD, National Institutes of Health, Bethesda, MD
(2)Section on Cellular Signaling, NICHD, National Institutes of Health, Bethesda, MD
(3)Department of Endocrinology, CHU de Liège-University of Liège, Liège, Belgium
(4)Department of Obstetrics and Gynecology, Uniformed Services University, Bethesda, MD
(5)Laboratory of Molecular Pharmacology, GIGA-Signal Transduction, University of Liège, Liege, Belgium
(6)Pathology, Centre Hospitalier Universitaire de Liège, Liège, Belgium
(7)Division of Developmental Biology, NICHD, National Institutes of Health, Bethesda, MD
(8)Department of Chemistry and Center for Behavioral Neuroscience, American University, Washington, DC
(9)Institute of Pharmacology and Toxicology, University of Würzburg and Bio-Imaging Center/Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany
Poster Board Number: SAT 105
Yong Bhum Song, PhD, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, boston, MA, Ana Paula Abreu, MD, PhD, Brigham and Women's Hospital and Harvard Medical School, Division of Endocrinology/Diabetes, Boston, MA, Rona S. Carroll, PhD, Division of Endocrinology/Diabetes, Brigham and Women's Hospital/Harvard Med School, Boston, MA and Ursula B. Kaiser, MD, Division of Endocrinolgy/Diabetes, Brigham Women's/Harvard Med School, Boston, MA
Poster Board Number: SAT 106
Gang Xi, PHD1, Christine Wai, B.S.1, Morris F White, PHD2, Clifford J Rosen, MD3 and David R Clemmons, MD1, (1)Dept of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
(2)Dept of Endo, Children's Hospital, Boston, MA
(3)Maine Medical Center Research Institute, Maine Medical Center, Scarborough, ME
Poster Board Number: SAT 117
Xin-Hua Liu, PHD, Dept of SCI Research, J.J. Peter VA Medical Center, Bronx, NY, Zachary A Graham, PhD, SCI Research, James J. Peter VA Medical Center, Bronx, NY, Lauren Harlow, BS, SCI Research, James J. Peter VA Medial Center, Bronx, NY, William A Bauman, MD, Center of Excellence for the Medical Consequences of SCI, James J. Peters VA Medical Center, Bronx, NY and Christopher Pratt Cardozo, BS, MD, Center of Excellence for the Medical Consequences of Spinal Cord Injury, James J. Peters Veteran Affairs Medical Center, Bronx, NY
Poster Board Number: SAT 128

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire